nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—CYP2D6—Alzheimer's disease	0.274	1	CbGaD
Propafenone—CYP2D6—Rivastigmine—Alzheimer's disease	0.0847	0.215	CbGbCtD
Propafenone—CYP2C9—Donepezil—Alzheimer's disease	0.074	0.188	CbGbCtD
Propafenone—CYP2D6—Donepezil—Alzheimer's disease	0.0677	0.172	CbGbCtD
Propafenone—CYP3A4—Rivastigmine—Alzheimer's disease	0.0538	0.136	CbGbCtD
Propafenone—CYP2D6—Galantamine—Alzheimer's disease	0.0436	0.111	CbGbCtD
Propafenone—CYP3A4—Donepezil—Alzheimer's disease	0.043	0.109	CbGbCtD
Propafenone—CYP3A4—Galantamine—Alzheimer's disease	0.0277	0.0703	CbGbCtD
Propafenone—Mirabegron—BCHE—Alzheimer's disease	0.000564	0.106	CrCbGaD
Propafenone—Benazepril—MTHFR—Alzheimer's disease	0.000457	0.0858	CrCbGaD
Propafenone—Quinapril—ACE—Alzheimer's disease	0.000429	0.0804	CrCbGaD
Propafenone—Phenoxybenzamine—CALM1—Alzheimer's disease	0.000396	0.0743	CrCbGaD
Propafenone—Benazepril—ACE—Alzheimer's disease	0.000373	0.07	CrCbGaD
Propafenone—Atomoxetine—HTR6—Alzheimer's disease	0.000371	0.0696	CrCbGaD
Propafenone—Carvedilol—VEGFA—Alzheimer's disease	0.000347	0.0651	CrCbGaD
Propafenone—Salsalate—PTGS1—Alzheimer's disease	0.000329	0.0617	CrCbGaD
Propafenone—Oxaprozin—PTGS1—Alzheimer's disease	0.000329	0.0617	CrCbGaD
Propafenone—Mirabegron—CYP2D6—Alzheimer's disease	0.00031	0.0581	CrCbGaD
Propafenone—Rhinitis—Memantine—Alzheimer's disease	0.000238	0.000862	CcSEcCtD
Propafenone—Haemorrhage—Memantine—Alzheimer's disease	0.000237	0.000859	CcSEcCtD
Propafenone—Hepatitis—Memantine—Alzheimer's disease	0.000237	0.000859	CcSEcCtD
Propafenone—Bradycardia—Rivastigmine—Alzheimer's disease	0.000236	0.000856	CcSEcCtD
Propafenone—Hypoaesthesia—Memantine—Alzheimer's disease	0.000236	0.000855	CcSEcCtD
Propafenone—Shock—Galantamine—Alzheimer's disease	0.000235	0.000854	CcSEcCtD
Propafenone—Nervous system disorder—Galantamine—Alzheimer's disease	0.000235	0.000851	CcSEcCtD
Propafenone—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000234	0.00085	CcSEcCtD
Propafenone—Urinary tract disorder—Memantine—Alzheimer's disease	0.000234	0.000849	CcSEcCtD
Propafenone—Tachycardia—Galantamine—Alzheimer's disease	0.000234	0.000847	CcSEcCtD
Propafenone—Arrhythmia—Donepezil—Alzheimer's disease	0.000233	0.000846	CcSEcCtD
Propafenone—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000233	0.000845	CcSEcCtD
Propafenone—Connective tissue disorder—Memantine—Alzheimer's disease	0.000233	0.000845	CcSEcCtD
Propafenone—Rhinitis—Rivastigmine—Alzheimer's disease	0.000232	0.000843	CcSEcCtD
Propafenone—Skin disorder—Galantamine—Alzheimer's disease	0.000232	0.000843	CcSEcCtD
Propafenone—Urethral disorder—Memantine—Alzheimer's disease	0.000232	0.000842	CcSEcCtD
Propafenone—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000232	0.000841	CcSEcCtD
Propafenone—Hepatitis—Rivastigmine—Alzheimer's disease	0.000232	0.000841	CcSEcCtD
Propafenone—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000231	0.000839	CcSEcCtD
Propafenone—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000231	0.000837	CcSEcCtD
Propafenone—Alopecia—Donepezil—Alzheimer's disease	0.000231	0.000836	CcSEcCtD
Propafenone—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000229	0.00083	CcSEcCtD
Propafenone—Mental disorder—Donepezil—Alzheimer's disease	0.000229	0.000829	CcSEcCtD
Propafenone—Visual impairment—Memantine—Alzheimer's disease	0.000228	0.000828	CcSEcCtD
Propafenone—Anorexia—Galantamine—Alzheimer's disease	0.000228	0.000827	CcSEcCtD
Propafenone—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000228	0.000826	CcSEcCtD
Propafenone—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000227	0.000824	CcSEcCtD
Propafenone—Erythema—Donepezil—Alzheimer's disease	0.000227	0.000824	CcSEcCtD
Propafenone—Malnutrition—Donepezil—Alzheimer's disease	0.000227	0.000824	CcSEcCtD
Propafenone—Flatulence—Donepezil—Alzheimer's disease	0.000224	0.000812	CcSEcCtD
Propafenone—Hypotension—Galantamine—Alzheimer's disease	0.000224	0.000811	CcSEcCtD
Propafenone—Visual impairment—Rivastigmine—Alzheimer's disease	0.000223	0.00081	CcSEcCtD
Propafenone—Tension—Donepezil—Alzheimer's disease	0.000223	0.000809	CcSEcCtD
Propafenone—Dysgeusia—Donepezil—Alzheimer's disease	0.000222	0.000807	CcSEcCtD
Propafenone—Eye disorder—Memantine—Alzheimer's disease	0.000221	0.000803	CcSEcCtD
Propafenone—Tinnitus—Memantine—Alzheimer's disease	0.000221	0.000801	CcSEcCtD
Propafenone—Nervousness—Donepezil—Alzheimer's disease	0.000221	0.0008	CcSEcCtD
Propafenone—Cardiac disorder—Memantine—Alzheimer's disease	0.00022	0.000798	CcSEcCtD
Propafenone—Flushing—Memantine—Alzheimer's disease	0.00022	0.000798	CcSEcCtD
Propafenone—Muscle spasms—Donepezil—Alzheimer's disease	0.000218	0.000792	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000218	0.000791	CcSEcCtD
Propafenone—Eye disorder—Rivastigmine—Alzheimer's disease	0.000217	0.000786	CcSEcCtD
Propafenone—Insomnia—Galantamine—Alzheimer's disease	0.000216	0.000785	CcSEcCtD
Propafenone—Tinnitus—Rivastigmine—Alzheimer's disease	0.000216	0.000784	CcSEcCtD
Propafenone—Flushing—Rivastigmine—Alzheimer's disease	0.000215	0.00078	CcSEcCtD
Propafenone—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000215	0.00078	CcSEcCtD
Propafenone—Angiopathy—Memantine—Alzheimer's disease	0.000215	0.00078	CcSEcCtD
Propafenone—Paraesthesia—Galantamine—Alzheimer's disease	0.000215	0.000779	CcSEcCtD
Propafenone—Vision blurred—Donepezil—Alzheimer's disease	0.000214	0.000777	CcSEcCtD
Propafenone—Immune system disorder—Memantine—Alzheimer's disease	0.000214	0.000776	CcSEcCtD
Propafenone—Mediastinal disorder—Memantine—Alzheimer's disease	0.000214	0.000775	CcSEcCtD
Propafenone—Tremor—Donepezil—Alzheimer's disease	0.000213	0.000772	CcSEcCtD
Propafenone—Somnolence—Galantamine—Alzheimer's disease	0.000213	0.000771	CcSEcCtD
Propafenone—Arrhythmia—Memantine—Alzheimer's disease	0.000212	0.000768	CcSEcCtD
Propafenone—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000211	0.000765	CcSEcCtD
Propafenone—Dyspepsia—Galantamine—Alzheimer's disease	0.000211	0.000764	CcSEcCtD
Propafenone—Angiopathy—Rivastigmine—Alzheimer's disease	0.00021	0.000763	CcSEcCtD
Propafenone—Anaemia—Donepezil—Alzheimer's disease	0.00021	0.000762	CcSEcCtD
Propafenone—Alopecia—Memantine—Alzheimer's disease	0.000209	0.000759	CcSEcCtD
Propafenone—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000209	0.000758	CcSEcCtD
Propafenone—Decreased appetite—Galantamine—Alzheimer's disease	0.000208	0.000754	CcSEcCtD
Propafenone—Mental disorder—Memantine—Alzheimer's disease	0.000208	0.000753	CcSEcCtD
Propafenone—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000207	0.000751	CcSEcCtD
Propafenone—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000207	0.000749	CcSEcCtD
Propafenone—Malnutrition—Memantine—Alzheimer's disease	0.000206	0.000748	CcSEcCtD
Propafenone—Fatigue—Galantamine—Alzheimer's disease	0.000206	0.000748	CcSEcCtD
Propafenone—Malaise—Donepezil—Alzheimer's disease	0.000205	0.000743	CcSEcCtD
Propafenone—Alopecia—Rivastigmine—Alzheimer's disease	0.000205	0.000743	CcSEcCtD
Propafenone—Constipation—Galantamine—Alzheimer's disease	0.000205	0.000742	CcSEcCtD
Propafenone—Vertigo—Donepezil—Alzheimer's disease	0.000204	0.00074	CcSEcCtD
Propafenone—Syncope—Donepezil—Alzheimer's disease	0.000204	0.000739	CcSEcCtD
Propafenone—Flatulence—Memantine—Alzheimer's disease	0.000203	0.000737	CcSEcCtD
Propafenone—Mental disorder—Rivastigmine—Alzheimer's disease	0.000203	0.000737	CcSEcCtD
Propafenone—Tension—Memantine—Alzheimer's disease	0.000202	0.000734	CcSEcCtD
Propafenone—Dysgeusia—Memantine—Alzheimer's disease	0.000202	0.000733	CcSEcCtD
Propafenone—Malnutrition—Rivastigmine—Alzheimer's disease	0.000202	0.000732	CcSEcCtD
Propafenone—Erythema—Rivastigmine—Alzheimer's disease	0.000202	0.000732	CcSEcCtD
Propafenone—Nervousness—Memantine—Alzheimer's disease	0.0002	0.000727	CcSEcCtD
Propafenone—Loss of consciousness—Donepezil—Alzheimer's disease	0.0002	0.000724	CcSEcCtD
Propafenone—Flatulence—Rivastigmine—Alzheimer's disease	0.000199	0.000721	CcSEcCtD
Propafenone—Cough—Donepezil—Alzheimer's disease	0.000198	0.000719	CcSEcCtD
Propafenone—Tension—Rivastigmine—Alzheimer's disease	0.000198	0.000718	CcSEcCtD
Propafenone—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000198	0.000717	CcSEcCtD
Propafenone—Feeling abnormal—Galantamine—Alzheimer's disease	0.000197	0.000715	CcSEcCtD
Propafenone—Convulsion—Donepezil—Alzheimer's disease	0.000197	0.000714	CcSEcCtD
Propafenone—Hypertension—Donepezil—Alzheimer's disease	0.000196	0.000711	CcSEcCtD
Propafenone—Nervousness—Rivastigmine—Alzheimer's disease	0.000196	0.000711	CcSEcCtD
Propafenone—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000196	0.00071	CcSEcCtD
Propafenone—Vision blurred—Memantine—Alzheimer's disease	0.000194	0.000705	CcSEcCtD
Propafenone—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000194	0.000704	CcSEcCtD
Propafenone—Chest pain—Donepezil—Alzheimer's disease	0.000193	0.000701	CcSEcCtD
Propafenone—Myalgia—Donepezil—Alzheimer's disease	0.000193	0.000701	CcSEcCtD
Propafenone—Tremor—Memantine—Alzheimer's disease	0.000193	0.000701	CcSEcCtD
Propafenone—Anxiety—Donepezil—Alzheimer's disease	0.000193	0.000699	CcSEcCtD
Propafenone—Ill-defined disorder—Memantine—Alzheimer's disease	0.000191	0.000694	CcSEcCtD
Propafenone—Discomfort—Donepezil—Alzheimer's disease	0.000191	0.000693	CcSEcCtD
Propafenone—Anaemia—Memantine—Alzheimer's disease	0.000191	0.000691	CcSEcCtD
Propafenone—Vision blurred—Rivastigmine—Alzheimer's disease	0.00019	0.00069	CcSEcCtD
Propafenone—Dry mouth—Donepezil—Alzheimer's disease	0.000189	0.000686	CcSEcCtD
Propafenone—Body temperature increased—Galantamine—Alzheimer's disease	0.000189	0.000686	CcSEcCtD
Propafenone—Abdominal pain—Galantamine—Alzheimer's disease	0.000189	0.000686	CcSEcCtD
Propafenone—Tremor—Rivastigmine—Alzheimer's disease	0.000189	0.000686	CcSEcCtD
Propafenone—Salsalate—PTGS2—Alzheimer's disease	0.000188	0.0353	CrCbGaD
Propafenone—Oxaprozin—PTGS2—Alzheimer's disease	0.000188	0.0353	CrCbGaD
Propafenone—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000187	0.000679	CcSEcCtD
Propafenone—Confusional state—Donepezil—Alzheimer's disease	0.000187	0.000678	CcSEcCtD
Propafenone—Anaemia—Rivastigmine—Alzheimer's disease	0.000187	0.000676	CcSEcCtD
Propafenone—Malaise—Memantine—Alzheimer's disease	0.000186	0.000675	CcSEcCtD
Propafenone—Oedema—Donepezil—Alzheimer's disease	0.000185	0.000672	CcSEcCtD
Propafenone—Vertigo—Memantine—Alzheimer's disease	0.000185	0.000672	CcSEcCtD
Propafenone—Syncope—Memantine—Alzheimer's disease	0.000185	0.000671	CcSEcCtD
Propafenone—Leukopenia—Memantine—Alzheimer's disease	0.000185	0.00067	CcSEcCtD
Propafenone—Infection—Donepezil—Alzheimer's disease	0.000184	0.000668	CcSEcCtD
Propafenone—Carvedilol—PTGS1—Alzheimer's disease	0.000183	0.0343	CrCbGaD
Propafenone—Shock—Donepezil—Alzheimer's disease	0.000182	0.000662	CcSEcCtD
Propafenone—Palpitations—Memantine—Alzheimer's disease	0.000182	0.000661	CcSEcCtD
Propafenone—Malaise—Rivastigmine—Alzheimer's disease	0.000182	0.00066	CcSEcCtD
Propafenone—Nervous system disorder—Donepezil—Alzheimer's disease	0.000182	0.000659	CcSEcCtD
Propafenone—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000182	0.000658	CcSEcCtD
Propafenone—Vertigo—Rivastigmine—Alzheimer's disease	0.000181	0.000658	CcSEcCtD
Propafenone—Loss of consciousness—Memantine—Alzheimer's disease	0.000181	0.000658	CcSEcCtD
Propafenone—Syncope—Rivastigmine—Alzheimer's disease	0.000181	0.000656	CcSEcCtD
Propafenone—Labetalol—CYP2D6—Alzheimer's disease	0.000181	0.034	CrCbGaD
Propafenone—Cough—Memantine—Alzheimer's disease	0.00018	0.000653	CcSEcCtD
Propafenone—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000179	0.00065	CcSEcCtD
Propafenone—Convulsion—Memantine—Alzheimer's disease	0.000179	0.000648	CcSEcCtD
Propafenone—Palpitations—Rivastigmine—Alzheimer's disease	0.000178	0.000647	CcSEcCtD
Propafenone—Hypertension—Memantine—Alzheimer's disease	0.000178	0.000646	CcSEcCtD
Propafenone—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000177	0.000643	CcSEcCtD
Propafenone—Anorexia—Donepezil—Alzheimer's disease	0.000177	0.000641	CcSEcCtD
Propafenone—Hypersensitivity—Galantamine—Alzheimer's disease	0.000176	0.000639	CcSEcCtD
Propafenone—Cough—Rivastigmine—Alzheimer's disease	0.000176	0.000639	CcSEcCtD
Propafenone—Chest pain—Memantine—Alzheimer's disease	0.000176	0.000637	CcSEcCtD
Propafenone—Myalgia—Memantine—Alzheimer's disease	0.000176	0.000637	CcSEcCtD
Propafenone—Anxiety—Memantine—Alzheimer's disease	0.000175	0.000635	CcSEcCtD
Propafenone—Convulsion—Rivastigmine—Alzheimer's disease	0.000175	0.000634	CcSEcCtD
Propafenone—Hypertension—Rivastigmine—Alzheimer's disease	0.000174	0.000632	CcSEcCtD
Propafenone—Discomfort—Memantine—Alzheimer's disease	0.000174	0.000629	CcSEcCtD
Propafenone—Hypotension—Donepezil—Alzheimer's disease	0.000173	0.000628	CcSEcCtD
Propafenone—Myalgia—Rivastigmine—Alzheimer's disease	0.000172	0.000623	CcSEcCtD
Propafenone—Chest pain—Rivastigmine—Alzheimer's disease	0.000172	0.000623	CcSEcCtD
Propafenone—Dry mouth—Memantine—Alzheimer's disease	0.000172	0.000623	CcSEcCtD
Propafenone—Asthenia—Galantamine—Alzheimer's disease	0.000172	0.000623	CcSEcCtD
Propafenone—Anxiety—Rivastigmine—Alzheimer's disease	0.000171	0.000621	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000171	0.000619	CcSEcCtD
Propafenone—Confusional state—Memantine—Alzheimer's disease	0.00017	0.000616	CcSEcCtD
Propafenone—Discomfort—Rivastigmine—Alzheimer's disease	0.00017	0.000616	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000169	0.000613	CcSEcCtD
Propafenone—Oedema—Memantine—Alzheimer's disease	0.000168	0.000611	CcSEcCtD
Propafenone—Dry mouth—Rivastigmine—Alzheimer's disease	0.000168	0.000609	CcSEcCtD
Propafenone—Insomnia—Donepezil—Alzheimer's disease	0.000168	0.000608	CcSEcCtD
Propafenone—Infection—Memantine—Alzheimer's disease	0.000167	0.000607	CcSEcCtD
Propafenone—Paraesthesia—Donepezil—Alzheimer's disease	0.000166	0.000604	CcSEcCtD
Propafenone—Confusional state—Rivastigmine—Alzheimer's disease	0.000166	0.000602	CcSEcCtD
Propafenone—Shock—Memantine—Alzheimer's disease	0.000166	0.000601	CcSEcCtD
Propafenone—Dyspnoea—Donepezil—Alzheimer's disease	0.000165	0.0006	CcSEcCtD
Propafenone—Nervous system disorder—Memantine—Alzheimer's disease	0.000165	0.000599	CcSEcCtD
Propafenone—Somnolence—Donepezil—Alzheimer's disease	0.000165	0.000598	CcSEcCtD
Propafenone—Thrombocytopenia—Memantine—Alzheimer's disease	0.000165	0.000598	CcSEcCtD
Propafenone—Oedema—Rivastigmine—Alzheimer's disease	0.000165	0.000597	CcSEcCtD
Propafenone—Tachycardia—Memantine—Alzheimer's disease	0.000164	0.000596	CcSEcCtD
Propafenone—Diarrhoea—Galantamine—Alzheimer's disease	0.000164	0.000594	CcSEcCtD
Propafenone—Infection—Rivastigmine—Alzheimer's disease	0.000164	0.000593	CcSEcCtD
Propafenone—Skin disorder—Memantine—Alzheimer's disease	0.000164	0.000593	CcSEcCtD
Propafenone—Dyspepsia—Donepezil—Alzheimer's disease	0.000163	0.000592	CcSEcCtD
Propafenone—Hyperhidrosis—Memantine—Alzheimer's disease	0.000163	0.00059	CcSEcCtD
Propafenone—Shock—Rivastigmine—Alzheimer's disease	0.000162	0.000588	CcSEcCtD
Propafenone—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000162	0.000586	CcSEcCtD
Propafenone—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000161	0.000585	CcSEcCtD
Propafenone—Decreased appetite—Donepezil—Alzheimer's disease	0.000161	0.000585	CcSEcCtD
Propafenone—Tachycardia—Rivastigmine—Alzheimer's disease	0.000161	0.000583	CcSEcCtD
Propafenone—Anorexia—Memantine—Alzheimer's disease	0.00016	0.000582	CcSEcCtD
Propafenone—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00016	0.000581	CcSEcCtD
Propafenone—Skin disorder—Rivastigmine—Alzheimer's disease	0.00016	0.00058	CcSEcCtD
Propafenone—Fatigue—Donepezil—Alzheimer's disease	0.00016	0.00058	CcSEcCtD
Propafenone—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000159	0.000577	CcSEcCtD
Propafenone—Constipation—Donepezil—Alzheimer's disease	0.000159	0.000575	CcSEcCtD
Propafenone—Pain—Donepezil—Alzheimer's disease	0.000159	0.000575	CcSEcCtD
Propafenone—Dizziness—Galantamine—Alzheimer's disease	0.000158	0.000574	CcSEcCtD
Propafenone—Hypotension—Memantine—Alzheimer's disease	0.000157	0.000571	CcSEcCtD
Propafenone—Anorexia—Rivastigmine—Alzheimer's disease	0.000157	0.000569	CcSEcCtD
Propafenone—Hypotension—Rivastigmine—Alzheimer's disease	0.000154	0.000558	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000153	0.000556	CcSEcCtD
Propafenone—Feeling abnormal—Donepezil—Alzheimer's disease	0.000153	0.000554	CcSEcCtD
Propafenone—Insomnia—Memantine—Alzheimer's disease	0.000152	0.000552	CcSEcCtD
Propafenone—Vomiting—Galantamine—Alzheimer's disease	0.000152	0.000552	CcSEcCtD
Propafenone—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000152	0.00055	CcSEcCtD
Propafenone—Paraesthesia—Memantine—Alzheimer's disease	0.000151	0.000548	CcSEcCtD
Propafenone—Rash—Galantamine—Alzheimer's disease	0.000151	0.000547	CcSEcCtD
Propafenone—Dermatitis—Galantamine—Alzheimer's disease	0.000151	0.000547	CcSEcCtD
Propafenone—Dyspnoea—Memantine—Alzheimer's disease	0.00015	0.000544	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00015	0.000544	CcSEcCtD
Propafenone—Headache—Galantamine—Alzheimer's disease	0.00015	0.000544	CcSEcCtD
Propafenone—Somnolence—Memantine—Alzheimer's disease	0.00015	0.000543	CcSEcCtD
Propafenone—Insomnia—Rivastigmine—Alzheimer's disease	0.000149	0.00054	CcSEcCtD
Propafenone—Dyspepsia—Memantine—Alzheimer's disease	0.000148	0.000537	CcSEcCtD
Propafenone—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000148	0.000536	CcSEcCtD
Propafenone—Urticaria—Donepezil—Alzheimer's disease	0.000147	0.000534	CcSEcCtD
Propafenone—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000147	0.000533	CcSEcCtD
Propafenone—Abdominal pain—Donepezil—Alzheimer's disease	0.000147	0.000532	CcSEcCtD
Propafenone—Body temperature increased—Donepezil—Alzheimer's disease	0.000147	0.000532	CcSEcCtD
Propafenone—Somnolence—Rivastigmine—Alzheimer's disease	0.000146	0.000531	CcSEcCtD
Propafenone—Decreased appetite—Memantine—Alzheimer's disease	0.000146	0.000531	CcSEcCtD
Propafenone—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000145	0.000527	CcSEcCtD
Propafenone—Fatigue—Memantine—Alzheimer's disease	0.000145	0.000526	CcSEcCtD
Propafenone—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000145	0.000526	CcSEcCtD
Propafenone—Pain—Memantine—Alzheimer's disease	0.000144	0.000522	CcSEcCtD
Propafenone—Constipation—Memantine—Alzheimer's disease	0.000144	0.000522	CcSEcCtD
Propafenone—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000143	0.000519	CcSEcCtD
Propafenone—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000142	0.000516	CcSEcCtD
Propafenone—Nausea—Galantamine—Alzheimer's disease	0.000142	0.000515	CcSEcCtD
Propafenone—Fatigue—Rivastigmine—Alzheimer's disease	0.000142	0.000515	CcSEcCtD
Propafenone—Atomoxetine—SLC6A4—Alzheimer's disease	0.000142	0.0266	CrCbGaD
Propafenone—Pain—Rivastigmine—Alzheimer's disease	0.000141	0.000511	CcSEcCtD
Propafenone—Constipation—Rivastigmine—Alzheimer's disease	0.000141	0.000511	CcSEcCtD
Propafenone—Feeling abnormal—Memantine—Alzheimer's disease	0.000139	0.000503	CcSEcCtD
Propafenone—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000138	0.000499	CcSEcCtD
Propafenone—Hypersensitivity—Donepezil—Alzheimer's disease	0.000137	0.000495	CcSEcCtD
Propafenone—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000136	0.000492	CcSEcCtD
Propafenone—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000135	0.000488	CcSEcCtD
Propafenone—Urticaria—Memantine—Alzheimer's disease	0.000134	0.000485	CcSEcCtD
Propafenone—Body temperature increased—Memantine—Alzheimer's disease	0.000133	0.000483	CcSEcCtD
Propafenone—Abdominal pain—Memantine—Alzheimer's disease	0.000133	0.000483	CcSEcCtD
Propafenone—Asthenia—Donepezil—Alzheimer's disease	0.000133	0.000482	CcSEcCtD
Propafenone—Pruritus—Donepezil—Alzheimer's disease	0.000131	0.000476	CcSEcCtD
Propafenone—Urticaria—Rivastigmine—Alzheimer's disease	0.000131	0.000475	CcSEcCtD
Propafenone—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00013	0.000472	CcSEcCtD
Propafenone—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00013	0.000472	CcSEcCtD
Propafenone—Diarrhoea—Donepezil—Alzheimer's disease	0.000127	0.00046	CcSEcCtD
Propafenone—Carvedilol—CYP2D6—Alzheimer's disease	0.000125	0.0234	CrCbGaD
Propafenone—Hypersensitivity—Memantine—Alzheimer's disease	0.000124	0.00045	CcSEcCtD
Propafenone—Dizziness—Donepezil—Alzheimer's disease	0.000123	0.000445	CcSEcCtD
Propafenone—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000121	0.00044	CcSEcCtD
Propafenone—Asthenia—Memantine—Alzheimer's disease	0.000121	0.000438	CcSEcCtD
Propafenone—Pruritus—Memantine—Alzheimer's disease	0.000119	0.000432	CcSEcCtD
Propafenone—Asthenia—Rivastigmine—Alzheimer's disease	0.000118	0.000429	CcSEcCtD
Propafenone—Vomiting—Donepezil—Alzheimer's disease	0.000118	0.000428	CcSEcCtD
Propafenone—Rash—Donepezil—Alzheimer's disease	0.000117	0.000424	CcSEcCtD
Propafenone—Dermatitis—Donepezil—Alzheimer's disease	0.000117	0.000424	CcSEcCtD
Propafenone—Pruritus—Rivastigmine—Alzheimer's disease	0.000117	0.000423	CcSEcCtD
Propafenone—Headache—Donepezil—Alzheimer's disease	0.000116	0.000421	CcSEcCtD
Propafenone—Diarrhoea—Memantine—Alzheimer's disease	0.000115	0.000418	CcSEcCtD
Propafenone—Dextropropoxyphene—CYP2D6—Alzheimer's disease	0.000115	0.0215	CrCbGaD
Propafenone—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000113	0.000409	CcSEcCtD
Propafenone—Dizziness—Memantine—Alzheimer's disease	0.000111	0.000404	CcSEcCtD
Propafenone—Nausea—Donepezil—Alzheimer's disease	0.00011	0.000399	CcSEcCtD
Propafenone—Atomoxetine—HTR2A—Alzheimer's disease	0.000109	0.0205	CrCbGaD
Propafenone—Dizziness—Rivastigmine—Alzheimer's disease	0.000109	0.000395	CcSEcCtD
Propafenone—Vomiting—Memantine—Alzheimer's disease	0.000107	0.000388	CcSEcCtD
Propafenone—Rash—Memantine—Alzheimer's disease	0.000106	0.000385	CcSEcCtD
Propafenone—Dermatitis—Memantine—Alzheimer's disease	0.000106	0.000385	CcSEcCtD
Propafenone—Headache—Memantine—Alzheimer's disease	0.000105	0.000383	CcSEcCtD
Propafenone—Vomiting—Rivastigmine—Alzheimer's disease	0.000105	0.00038	CcSEcCtD
Propafenone—Rash—Rivastigmine—Alzheimer's disease	0.000104	0.000377	CcSEcCtD
Propafenone—Dermatitis—Rivastigmine—Alzheimer's disease	0.000104	0.000376	CcSEcCtD
Propafenone—Headache—Rivastigmine—Alzheimer's disease	0.000103	0.000374	CcSEcCtD
Propafenone—Nausea—Memantine—Alzheimer's disease	0.0001	0.000363	CcSEcCtD
Propafenone—Atomoxetine—CYP2D6—Alzheimer's disease	9.97e-05	0.0187	CrCbGaD
Propafenone—Nausea—Rivastigmine—Alzheimer's disease	9.78e-05	0.000355	CcSEcCtD
Propafenone—Propranolol—CYP2D6—Alzheimer's disease	9.47e-05	0.0178	CrCbGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.71e-05	0.000341	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	1.71e-05	0.000341	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PSEN2—Alzheimer's disease	1.71e-05	0.000341	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.69e-05	0.000337	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.69e-05	0.000337	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CCR5—Alzheimer's disease	1.65e-05	0.000329	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	1.64e-05	0.000327	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.61e-05	0.000322	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.6e-05	0.00032	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.59e-05	0.000318	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PRKCG—Alzheimer's disease	1.58e-05	0.000315	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	1.58e-05	0.000315	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NPY—Alzheimer's disease	1.57e-05	0.000313	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	1.57e-05	0.000313	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IAPP—Alzheimer's disease	1.56e-05	0.000312	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.55e-05	0.00031	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.54e-05	0.000307	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ND1—Alzheimer's disease	1.52e-05	0.000304	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CRH—Alzheimer's disease	1.52e-05	0.000302	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CCR5—Alzheimer's disease	1.5e-05	0.000298	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.49e-05	0.000297	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.46e-05	0.000292	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.46e-05	0.000291	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	1.45e-05	0.000289	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NPS—Alzheimer's disease	1.44e-05	0.000287	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.43e-05	0.000285	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—IL6—Alzheimer's disease	1.42e-05	0.000283	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—F2—Alzheimer's disease	1.41e-05	0.000282	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—TPI1—Alzheimer's disease	1.41e-05	0.000282	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CHAT—Alzheimer's disease	1.41e-05	0.000282	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PTK2B—Alzheimer's disease	1.41e-05	0.000281	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.39e-05	0.000278	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.38e-05	0.000276	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.37e-05	0.000274	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SST—Alzheimer's disease	1.37e-05	0.000274	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—GAB2—Alzheimer's disease	1.37e-05	0.000274	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NTRK2—Alzheimer's disease	1.37e-05	0.000274	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CALM1—Alzheimer's disease	1.37e-05	0.000272	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.36e-05	0.000272	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—GSK3A—Alzheimer's disease	1.36e-05	0.000271	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—MAOB—Alzheimer's disease	1.35e-05	0.00027	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—APP—Alzheimer's disease	1.34e-05	0.000267	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.33e-05	0.000266	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.32e-05	0.000263	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—AKT1—Alzheimer's disease	1.31e-05	0.000261	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	1.3e-05	0.00026	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.29e-05	0.000257	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—F2—Alzheimer's disease	1.28e-05	0.000256	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.28e-05	0.000255	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.27e-05	0.000252	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PLCB1—Alzheimer's disease	1.26e-05	0.000252	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—A2M—Alzheimer's disease	1.26e-05	0.000251	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.25e-05	0.000249	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.24e-05	0.000248	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CHAT—Alzheimer's disease	1.23e-05	0.000245	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—TPI1—Alzheimer's disease	1.23e-05	0.000245	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.22e-05	0.000243	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—MAOB—Alzheimer's disease	1.18e-05	0.000235	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NGFR—Alzheimer's disease	1.18e-05	0.000235	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.18e-05	0.000235	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.17e-05	0.000234	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CREB1—Alzheimer's disease	1.17e-05	0.000233	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.16e-05	0.000231	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.16e-05	0.000231	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ADAM10—Alzheimer's disease	1.15e-05	0.000229	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.15e-05	0.000229	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.15e-05	0.000229	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CCL2—Alzheimer's disease	1.14e-05	0.000228	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GAPDH—Alzheimer's disease	1.14e-05	0.000226	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.12e-05	0.000224	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.11e-05	0.000222	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.1e-05	0.00022	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—A2M—Alzheimer's disease	1.1e-05	0.000219	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.1e-05	0.000219	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ACHE—Alzheimer's disease	1.1e-05	0.000218	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—S100B—Alzheimer's disease	1.09e-05	0.000217	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	1.08e-05	0.000216	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	1.07e-05	0.000213	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.07e-05	0.000213	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1.06e-05	0.000212	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.05e-05	0.000209	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.04e-05	0.000207	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IGF2—Alzheimer's disease	1.04e-05	0.000206	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—A2M—Alzheimer's disease	1.03e-05	0.000206	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	1.03e-05	0.000205	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ENO1—Alzheimer's disease	1.03e-05	0.000205	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—A2M—Alzheimer's disease	1.02e-05	0.000204	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	1.01e-05	0.000201	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IGF1R—Alzheimer's disease	1e-05	0.0002	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—TPI1—Alzheimer's disease	9.82e-06	0.000196	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CHAT—Alzheimer's disease	9.82e-06	0.000196	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—LPL—Alzheimer's disease	9.6e-06	0.000191	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ACHE—Alzheimer's disease	9.54e-06	0.00019	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—BCHE—Alzheimer's disease	9.54e-06	0.00019	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MEF2C—Alzheimer's disease	9.51e-06	0.00019	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—INPP5D—Alzheimer's disease	9.43e-06	0.000188	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—MAOB—Alzheimer's disease	9.42e-06	0.000188	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PRKCG—Alzheimer's disease	9.33e-06	0.000186	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	9.26e-06	0.000185	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.14e-06	0.000182	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NGF—Alzheimer's disease	9.09e-06	0.000181	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	9.07e-06	0.000181	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	9e-06	0.000179	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ACHE—Alzheimer's disease	8.99e-06	0.000179	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	8.96e-06	0.000179	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTGS1—Alzheimer's disease	8.94e-06	0.000178	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ENO1—Alzheimer's disease	8.94e-06	0.000178	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ACHE—Alzheimer's disease	8.91e-06	0.000178	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	8.89e-06	0.000177	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	8.88e-06	0.000177	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCR5—Alzheimer's disease	8.84e-06	0.000176	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	8.83e-06	0.000176	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	8.81e-06	0.000176	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	8.77e-06	0.000175	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—A2M—Alzheimer's disease	8.76e-06	0.000175	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	8.73e-06	0.000174	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	8.65e-06	0.000172	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ENO1—Alzheimer's disease	8.43e-06	0.000168	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	8.43e-06	0.000168	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	8.35e-06	0.000167	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ENO1—Alzheimer's disease	8.35e-06	0.000167	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—BCHE—Alzheimer's disease	8.31e-06	0.000166	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	8.19e-06	0.000163	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	8.07e-06	0.000161	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	8.04e-06	0.00016	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	8.04e-06	0.00016	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	7.97e-06	0.000159	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PLCB1—Alzheimer's disease	7.84e-06	0.000156	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—BCHE—Alzheimer's disease	7.83e-06	0.000156	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.81e-06	0.000156	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—BCHE—Alzheimer's disease	7.77e-06	0.000155	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	7.68e-06	0.000153	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ACHE—Alzheimer's disease	7.62e-06	0.000152	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ABCA1—Alzheimer's disease	7.6e-06	0.000152	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—F2—Alzheimer's disease	7.59e-06	0.000151	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—TPI1—Alzheimer's disease	7.58e-06	0.000151	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CHAT—Alzheimer's disease	7.58e-06	0.000151	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	7.53e-06	0.00015	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	7.52e-06	0.00015	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	7.49e-06	0.000149	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	7.42e-06	0.000148	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	7.39e-06	0.000147	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	7.33e-06	0.000146	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MAOB—Alzheimer's disease	7.27e-06	0.000145	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.19e-06	0.000143	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	7.16e-06	0.000143	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	7.14e-06	0.000142	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ENO1—Alzheimer's disease	7.14e-06	0.000142	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	7.1e-06	0.000142	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	7e-06	0.00014	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	7e-06	0.000139	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	6.97e-06	0.000139	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	6.91e-06	0.000138	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—INS—Alzheimer's disease	6.87e-06	0.000137	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—LPL—Alzheimer's disease	6.85e-06	0.000137	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	6.76e-06	0.000135	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—A2M—Alzheimer's disease	6.76e-06	0.000135	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	6.65e-06	0.000133	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—BCHE—Alzheimer's disease	6.64e-06	0.000132	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	6.55e-06	0.000131	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—HMOX1—Alzheimer's disease	6.52e-06	0.00013	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	6.26e-06	0.000125	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	6.18e-06	0.000123	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	6.17e-06	0.000123	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	6.15e-06	0.000123	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.14e-06	0.000122	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	6.12e-06	0.000122	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	6.09e-06	0.000121	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	6.07e-06	0.000121	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	6.03e-06	0.00012	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—LPL—Alzheimer's disease	5.97e-06	0.000119	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ACHE—Alzheimer's disease	5.88e-06	0.000117	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	5.81e-06	0.000116	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CALM1—Alzheimer's disease	5.76e-06	0.000115	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—APOE—Alzheimer's disease	5.74e-06	0.000114	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CAV1—Alzheimer's disease	5.69e-06	0.000113	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—LPL—Alzheimer's disease	5.62e-06	0.000112	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—LPL—Alzheimer's disease	5.57e-06	0.000111	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ENO1—Alzheimer's disease	5.51e-06	0.00011	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	5.51e-06	0.00011	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	5.4e-06	0.000108	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—MTHFR—Alzheimer's disease	5.37e-06	0.000107	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	5.23e-06	0.000104	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	5.21e-06	0.000104	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	5.16e-06	0.000103	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—BCHE—Alzheimer's disease	5.12e-06	0.000102	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	5.12e-06	0.000102	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	5.08e-06	0.000101	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	5.06e-06	0.000101	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CALM1—Alzheimer's disease	5.02e-06	0.0001	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	5.02e-06	0.0001	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—APOE—Alzheimer's disease	5e-06	9.97e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PPARG—Alzheimer's disease	5e-06	9.97e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CAV1—Alzheimer's disease	4.96e-06	9.88e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—INS—Alzheimer's disease	4.9e-06	9.78e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.83e-06	9.63e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—LPL—Alzheimer's disease	4.76e-06	9.49e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4.73e-06	9.43e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—APOE—Alzheimer's disease	4.71e-06	9.39e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	4.7e-06	9.37e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	4.69e-06	9.35e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CALM1—Alzheimer's disease	4.69e-06	9.35e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	4.68e-06	9.34e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—APOE—Alzheimer's disease	4.67e-06	9.31e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CAV1—Alzheimer's disease	4.67e-06	9.31e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CAV1—Alzheimer's disease	4.63e-06	9.23e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PPARG—Alzheimer's disease	4.36e-06	8.68e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	4.34e-06	8.65e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NOS3—Alzheimer's disease	4.3e-06	8.57e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	4.29e-06	8.55e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—INS—Alzheimer's disease	4.27e-06	8.52e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PPARG—Alzheimer's disease	4.1e-06	8.18e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PPARG—Alzheimer's disease	4.07e-06	8.11e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	4.04e-06	8.05e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—INS—Alzheimer's disease	4.03e-06	8.03e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	4.02e-06	8.01e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CALM1—Alzheimer's disease	4.01e-06	7.99e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APOE—Alzheimer's disease	3.99e-06	7.96e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—INS—Alzheimer's disease	3.99e-06	7.96e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	3.98e-06	7.94e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CAV1—Alzheimer's disease	3.96e-06	7.89e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	3.93e-06	7.84e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NOS3—Alzheimer's disease	3.75e-06	7.47e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.68e-06	7.33e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.53e-06	7.04e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NOS3—Alzheimer's disease	3.5e-06	6.98e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PPARG—Alzheimer's disease	3.48e-06	6.93e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTGS2—Alzheimer's disease	3.43e-06	6.83e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—INS—Alzheimer's disease	3.41e-06	6.8e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.31e-06	6.6e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	3.28e-06	6.54e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	3.23e-06	6.44e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	3.2e-06	6.38e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CALM1—Alzheimer's disease	3.09e-06	6.16e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOE—Alzheimer's disease	3.08e-06	6.14e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CAV1—Alzheimer's disease	3.05e-06	6.09e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	3e-06	5.99e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NOS3—Alzheimer's disease	2.99e-06	5.96e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	2.77e-06	5.52e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	2.74e-06	5.45e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.68e-06	5.35e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—INS—Alzheimer's disease	2.63e-06	5.25e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.31e-06	4.6e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.11e-06	4.21e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—AKT1—Alzheimer's disease	1.98e-06	3.94e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.72e-06	3.43e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.62e-06	3.24e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.61e-06	3.21e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.37e-06	2.74e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.06e-06	2.12e-05	CbGpPWpGaD
